We are live on ! Find out more
Morgan Stanley

Morgan Stanley Portfolio holdings

AUM $1.66T
1-Year Est. Return 25.57%
 

Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.

This Fund
S&P 500
This Quarter Est. Return
+28.45%
1 Year Est. Return
+25.57%
3 Year Est. Return
+85.95%
5 Year Est. Return
+96.01%
10 Year Est. Return
+409.32%
AUM
$452B
AUM Growth
+$83.8B
Cap. Flow
-$1.84B
Cap. Flow %
-0.41%
Top 10 Hldgs %
16.9%
Holding
6,941
New
185
Increased
3,288
Reduced
2,645
Closed
222

Sector Composition

Rank Sector Weight
1 Technology 19.32%
2 Healthcare 10.4%
3 Consumer Discretionary 8.1%
4 Communication Services 7.82%
5 Financials 7.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ITEQ icon
5301
Amplify BlueStar Israel Technology ETF
ITEQ
$112M
$89K ﹤0.01%
1,879
-240
-11% -$10.4K
KURE icon
5302
KraneShares MSCI All China Health Care Index ETF
KURE
$98.5M
$89K ﹤0.01%
+2,800
New +$76.8K
NNDM
5303
Nano Dimension
NNDM
$316M
$89K ﹤0.01%
40,874
+40,774
+40,774% +$68.1K
WEYS icon
5304
Weyco Group
WEYS
$372M
$89K ﹤0.01%
4,141
+195
+5% +$3.79K
HZN
5305
DELISTED
Horizon Global Corporation
HZN
$89K ﹤0.01%
40,480
+7,875
+24% +$14.4K
BBP icon
5306
Virtus Biotech ETF
BBP
$93.9M
$88K ﹤0.01%
1,861
+18
+1% +$804
BH icon
5307
Biglari Holdings Class B
BH
$1.25B
$88K ﹤0.01%
1,279
+1,076
+530% +$69.2K
GEG icon
5308
Great Elm Group
GEG
$67.4M
$88K ﹤0.01%
37,719
-1
-0% -$2
DBGR
5309
DELISTED
Xtrackers MSCI Germany Hedged Equity ETF
DBGR
$88K ﹤0.01%
3,335
-2,294
-41% -$56.3K
SPNE
5310
DELISTED
SeaSpine Holdings Corporation Common Stock
SPNE
$88K ﹤0.01%
8,397
+6,417
+324% +$65.6K
CDOR
5311
DELISTED
Condor Hospitality Trust, Inc. Common Stock
CDOR
$88K ﹤0.01%
21,493
+1,384
+7% +$5.34K
CTG
5312
DELISTED
Computer Task Group, Inc.
CTG
$87K ﹤0.01%
21,685
+11,591
+115% +$47.4K
BXG
5313
DELISTED
Bluegreen Vacations Corporation Common Stock
BXG
$87K ﹤0.01%
15,959
+8,005
+101% +$38.2K
CBL
5314
DELISTED
CBL& Associates Properties, Inc.
CBL
$87K ﹤0.01%
321,192
-244,604
-43% -$64.9K
ESQ icon
5315
Esquire Financial Holdings
ESQ
$1.12B
$86K ﹤0.01%
5,067
-786
-13% -$12.5K
GNSS icon
5316
Genasys
GNSS
$76.1M
$86K ﹤0.01%
17,816
+2,636
+17% +$11.6K
SUZ icon
5317
Suzano
SUZ
$10.5B
$86K ﹤0.01%
12,658
-78,844
-86% -$575K
NVCN
5318
DELISTED
Neovasc Inc.
NVCN
$86K ﹤0.01%
1,449
-1,072
-43% -$66.9K
RUHN
5319
DELISTED
Ruhnn Holding Limited American Depositary Shares
RUHN
$86K ﹤0.01%
29,000
+15,050
+108% +$51.5K
APYX icon
5320
Apyx Medical
APYX
$173M
$85K ﹤0.01%
15,427
+7,219
+88% +$30K
IPHA
5321
Innate Pharma
IPHA
$164M
$85K ﹤0.01%
12,441
+9,141
+277% +$61.2K
CTOS icon
5322
Custom Truck One Source
CTOS
$2.31B
$84K ﹤0.01%
21,011
+4,433
+27% +$12.9K
RFIL icon
5323
RF Industries
RFIL
$134M
$84K ﹤0.01%
17,950
SNCR
5324
DELISTED
Synchronoss Technologies
SNCR
$84K ﹤0.01%
2,639
-462
-15% -$12.7K
TRNS icon
5325
Transcat
TRNS
$799M
$84K ﹤0.01%
3,219
+1,357
+73% +$35.3K

Similar funds

Morgan Stanley's Q2 2020 Portfolio in Review

As of Q2 2020, Morgan Stanley held 6,941 positions worth $452B, up 23% from $368B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Morgan Stanley's Q2 2020 filing shows 185 new, 3,288 increased, 2,645 reduced and 222 closed positions. Its largest new stake was Royalty Pharma: 6,205,186 shares worth $301M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $5.07B.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 16% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Morgan Stanley's largest Q2 2020 buy was Royalty Pharma: 6,205,186 shares worth $301M.
  • Morgan Stanley added most to Block Inc in Q2 2020, an estimated $1.53B increase.
  • Morgan Stanley's biggest Q2 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $5.07B.
  • Morgan Stanley fully exited Allergan plc in Q2 2020, selling an estimated $487M.
  • Morgan Stanley's ten largest holdings make up 17% of its $452B portfolio in Q2 2020.
  • Morgan Stanley opened 185 new positions and closed 222 in Q2 2020.
  • Morgan Stanley's portfolio value rose 23% quarter-over-quarter to $452B.

Based on Morgan Stanley's 13F filing for Q2 2020, filed 14 Aug 2020.